Background. The relevance of borderline change (BL) and subclinical cellular rejection (SCR) observed in renal transplantation remains to be determined. Several studies have shown in BL and SCR the presence of a Th1 immune response, qualitatively similar to but quantitatively reduced in comparison with infiltrates typical of acute cellular rejection (ACR). Methods. To elucidate the role of regulatory T cells (Tregs) in the local control of the allogenic response, we studied their presence by immunohistochemistry in 24 biopsies with graft dysfunction (12 ACR and 12 BL) and in 16 protocol biopsies at 1 year (eight SCR and eight subclinical BL).
T he concept of immunoregulation in organ transplantation appeared in the 1980s with the description of transplantation tolerance in the adult mouse, brought by infusing allogenic donor marrow under the cover of therapeutic CD4 and CD8 antibodies (1, 2) . It was not until 1995 that a population of suppressive CD4 ϩ
CD25
ϩ lymphocytes was identified, named regulatory T cells (Tregs) (3) . In humans, these cells are mainly within the CD25 bright FoxP3 bright subset of CD4 ϩ T cells, (4, 5) where they play a major role in the control of immune responses against self and exogenous antigens (6, 7) .
In animal models, Tregs in the transplant allograft are required for the induction and maintenance of transplantation tolerance (8 -10) . By contrast, in human organ transplantation, the presence of FoxP3 ϩ T cells in the graft has been observed during the allogenic inflammation process (11) . This suggests a role for human Tregs at a later stage of the alloimmune response, in particular in damage control. However, the significance of their presence in the renal graft and their ability to control the allogenic inflammation remain controversial. In patients with graft dysfunction, higher FoxP3 mRNA levels have been found in the urine and in the grafts of patients with acute cellular rejection (ACR), in comparison with patients without rejection (12) . Urinary FoxP3 mRNA levels correlated positively with reversibility of rejection and reduction of graft loss at 6 months. Immunohistochemical study of FoxP3 showed more FoxP3 protein in ACR compared with acute humoral rejection (13) . However, the in situ expression level of FoxP3 was not correlated with a favorable outcome of ACR. In a similar study, no correlation was found between intragraft FoxP3 mRNA levels and favorable outcome in 28 cases of ACR (14) . The role of Tregs has also been studied in borderline change (BL), where it was observed that the FoxP3/Granzyme B ratio was higher compared with that seen in ACR (15) . Strong expression of intragraft FoxP3 mRNA was associated with stability of histologic lesions and favorable evolution at 1 month (16) . A favorable role for Tregs on the course of subclinical cellular rejection (SCR) was also found (17) , and the presence of FoxP3 protein in the graft was correlated with increased graft function at 2 years after transplantation.
The contradictory data on the role of Tregs in the favorable versus unfavorable course of graft function result in part from the lack of specificity of the FoxP3 transcription factor for the Tregs population. In human, transitory lowlevel FoxP3 expression is seen in the course of effector T-cell activation (18) . Immunosuppressive memory Tregs are distinguished by a high level of FoxP3 expression (18, 19) . It seems likely that the use of too sensitive techniques to quantify mRNA FoxP3 by reverse-transcriptase polymerase chain reaction detects not only Tregs but also activated T effector cells.
Therefore, we investigated the role of Tregs in the local control of the allogenic response, with a previously described validated immunohistochemical technique detecting Tregs in renal grafts (20) . Their presence was compared in BL and ACR with or without graft dysfunction. Finally, the associations between the presence of Tregs in the renal transplant, inflammatory response intensity, and graft function at the time of the biopsy were studied.
PATIENTS AND METHODS

Patients and Renal Biopsies
Our Graft function was assessed by serum creatinine (SCr) levels at the time of biopsy.
Detection of CD4
؉ FoxP3 ؉ T Cells in Biopsy Material CD4 ϩ FoxP3 ϩ cells were detected in biopsies fixed in alcohol-formol-acetic acid embedded in paraffin as previously described (20) .
The double immunofluorescence CD4 ϩ FoxP3 ϩ was analyzed using a Zeiss LSM 510 microscope with confocal laser. All images were taken using a 60ϫ objective. CD4 
Histopathology
Graft biopsies were stained routinely for light microscopic study. The cellular infiltration was analyzed on immunoperoxi- dase using monoclonal antibodies to CD3 (Neomarker; Fremont, CA), CD8, CD20, and CD68 (Dako; Glostrub, Denmark). The presence of eosinophils in the infiltrates was evaluated by standard morphologic criteria. The mean percentage of each population in the cellular infiltrate was established by counting five fields at 40ϫ.
The following specific lesions were evaluated on the biopsies according to the Banff classification: intersitial inflammation, tubulitis, glomerulitis of rejection, dilatation and cellular infiltration of peritubular capillaries, and vascular lesions of rejection. Staining for C4d was performed on fixed, paraffinembedded sections, and it was negative for all patients.
Statistical Analysis
Results were expressed as the meanϮSD. The correlation between the percentage of CD4 ϩ FoxP3 ϩ cells, SCr, and histologic parameters was calculated using Pearson product moment correlation and Spearman rank order correlation respectively. Mann-Whitney U tests were used to compare variables deviating from normal distribution. P less than 0.05 was considered significant. Software used was Statistica 6 (Statsoft, Tulsa, OK).
RESULTS
Borderline Change Are Enriched in Memory Tregs as Compared With Acute Cellular Rejection
The markers CD3, CD8, CD20, and CD68 were compared in 12 BL and 12 ACR. The infiltrates in both were primarily composed of CD3 ϩ cells (Table 2 ). Of these, more than 70% were CD4 ϩ , with CD8 ϩ cells primarily located in tubules and vessels. The remainder of the infiltrates were composed of CD68 ϩ cells, and rare CD20 ϩ nodular infiltrates (Ͻ10%) were seen. Eosinophils were absent from the infiltrates of both groups. These observations show a qualitatively similar but quantitatively lower effector response in the BL group compared with the ACR group.
Next, we evaluated the presence of Tregs in these infiltrates. The FoxP3 ϩ cells quantified through confocal microscopy on paraffin sections were analyzed within the CD4 ϩ infiltrates of both groups. We have previously shown that this technique on fixed specimens only detects FoxP3 bright cells, thus identifying memory Treg cells, the FoxP3 low cells (including naïve Tregs and effector T cells) remaining below the threshold of detection (20) . As shown in Figure 1 , the Treg proportion was lower in the CD4 ϩ infiltrates in ACR when compared with BL (1.58%Ϯ1.92% of CD4 ϩ cells, nϭ12, vs. 4.11%Ϯ2.49%, nϭ12, Pϭ0.015).
These results show that Tregs are associated with a lower inflammation response, suggesting that they are implicated in the lower effector response in the BL group compared with the ACR group.
Higher Percentage of Memory Tregs in Infiltrates in the Absence of Graft Dysfunction
We then studied the influence of Tregs on the clinical expression of the infiltrates posttransplant. Their presence was compared by the same immunohistochemical technique in infiltrates with (ACR) or without graft dysfunction (SCR). As shown in Figure 2 (Table 2 ). These data suggest that the effects of ACR and BL on renal function depend not only on the effector response but also on the presence of Tregs permitting regulation of the effector response.
The Presence In Situ of Tregs Is Correlated With the Intensity of Interstitial Inflammation and Graft Function at the Time of the Biopsy
Finally, we addressed the question of whether intragraft Tregs had an impact on the intensity of the inflammatory response and graft function at the time of biopsy. No corre- Fig. 3 ). These data suggest a protective role of Tregs during the allogenic response in controlling interstitial inflammation and its associated lesions. 
DISCUSSION
The Banff classification has permitted the establishment of uniform therapeutic strategies for treatment of ACR and more recently antibody-mediated rejection (21) . However, the nature and significance of borderline and subclinical changes remain uncertain (22) . Recently, microarray analysis has permitted a more precise study of the nature of the inflammatory response associated with these infiltrates. Halloran and coworkers (23) have shown that the expression of transcripts associated with the T-dependent allogenic response was qualitatively the same in ACR and BL, but quantitatively diminished in the latter. Similarly, Hoffmann et al. (24) have shown the expression in SCR of transcripts associated with the Th1 response, including the transcription factor Tbet and the effector molecules Fas Ligand (FasL), interferon-␥, perforin, and granzyme B. Interestingly, the nature of the transcripts was the same in SCR and ACR, but with higher expression of Tbet and FasL in ACR. These data suggest an immune response that is qualitatively similar but quantitatively reduced in BL and SCR compared with ACR. Our study revealing an equivalent proportion of CD4 ϩ and CD8 ϩ T cells, B cells, macrophages, and the absence of eosinophils in BL and ACR, with or without graft dysfunction, support this hypothesis. Moreover, we have observed a higher percentage of Tregs in BL, and more generally a negative correlation between the presence of Tregs in the graft and the intensity of interstitial inflammation. These results suggest a local suppression of the inflammatory reaction by allospecific Tregs previously activated in the lymphoid organs and migrating into the graft. Two mechanisms might thus explain the diminution of interstitial inflammation: either suppression of effector T-cell recruitment into the graft or inhibition of their proliferation in situ. Recently, Wood and coworkers (25) have shown, in a transgenic mouse model in which tolerance was induced after skin grafting, that there is a migration of allospecific Tregs into the graft, leading to local suppression of the generation of memory T cells from effector T cells already present in the graft. Memory T cells are characterized by marked proliferation in response to antigens and increased secretion of certain chemokines, such as regulated on activation normal T-cell expressed and secreted and inducible protein-10 (26, 27) . These chemokines play a key role in the recruitment of allospecific T cells into the graft (28) . It is, therefore, possible that the Tregs suppress memory T cells and thus decrease the intensity of the inflammatory reaction, leading to BL and not to fullfledged ACR.
Moreover, the observation in this study of an increase in Tregs in SCR and of a negative correlation between their presence in the graft and graft function at the time of biopsy suggest that they also play a role in the inhibition of parenchymal insult associated with the allogenic inflammatory reaction. For example, apoptosis of tubular epithelial cells via the interaction of Fas and its ligand expressed by activated CD4 ϩ cells is one of the mechanisms described in graft dysfunction in ACR (28) . In view of the transcriptional data observed in SCR, showing diminished expression of FasL in comparison with ACR, it may be hypothesized that effector T-cell activation is locally suppressed in SCR, thus inhibiting apoptosis of renal tubular cells and permitting maintenance of renal function.
Our results suggest a beneficial effect of Tregs in the graft, inhibiting acute allogenic inflammation and tissue injury, and raise the question of their diagnostic value for rejection in kidney transplantation (29) . Presently, the diagnosis of rejection in kidney transplantation, but also in other solid organ transplantation such as heart transplantation, is made on histologic evaluation of the grafted tissue. Consequently, the decision to treat depends on the infiltrate and not on the deterioration of graft function. The observation presented here may have an important bearing in the clinical situation, especially on the treatment of subclinical infiltrates. Indeed, it is likely that the systematic treatment of these infiltrates results in disappearance not only of effectors of allogenic inflammation but also in some cases of beneficial mononuclear cells infiltrating the graft, such as Tregs, that are falsely identified as mediators of rejection. Thus, to address the question not only of the diagnostic but also of the prognostic value of Tregs in the allogenic inflammatory infiltrate, a prospective multicenter study is needed, comparing two groups of patients with subclinical infiltrates, treated or not, where the functional and histologic evolution can be correlated with the level of Tregs in the initial biopsy. Definitive data on this question would establish the putative beneficial effect of Tregs infiltration in allogenic inflammation, allowing accurate assessment of individual patients' immunologic risk to tailor immunosuppressive treatments to these different levels of risk. In conclusion, we have shown that BL and SCR have equivalent proportions of the different effector cell types compared with ACR, but they are distinguished from the latter by an increased percentage of Tregs in the CD4 ϩ infiltrate. The presence of Tregs in the graft was correlated with the intensity of the inflammatory reaction and renal function at the time of biopsy. These observations suggest an initial beneficial effect of Tregs in the graft and need to be extended to determine the correlation with graft outcome.
